Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences.

  • BofA Securities 2024 Healthcare Conference in Las Vegas Fireside Chat on Wednesday, May 15 at 10:40 a.m. PT / 1:40 p.m. ET
  • Leerink Partners 2024 Healthcare Crossroads Conference in Austin, Texas Fireside Chat on Wednesday, May 29 at 3:00 p.m. CT / 4:00 p.m. ET

Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.

Investor Contact: investors@guardanthealth.com

Media Contact: Melissa Marasco press@guardanthealth.com +1 650-647-3711

Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Guardant Health.
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Guardant Health.